Name: Lung Cancer Screening (en Inglés)
Price: 89240.00 CLP
Availability: InStock
Author: Parker, Mark ; Groves, Robert ; Kusmirek, Joanna
ISBN: 9781626235137

portada Lung Cancer Screening (en Inglés)

Formato

Libro Físico

Autor

Mark Parker

Robert Groves

Joanna Kusmirek

Editorial

Thieme Medical Publishers

Idioma

Inglés

N° páginas

120

Encuadernación

Tapa Blanda

Dimensiones

23.1 x 15.5 x 1.0 cm

Peso

0.27 kg.

ISBN13

9781626235137

Categorías

Radioterapia
Medicina nuclear
Técnicas de diagnóstico por la imagen: radiología

Lung Cancer Screening (en Inglés)

Mark Parker (Autor) · Robert Groves (Autor) · Joanna Kusmirek (Autor) · Thieme Medical Publishers · Tapa Blanda

Libro Nuevo Importado

Envío: 13 a 18 días háb.

$ 178.470$ 89.240

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Última Unidad

$ 89.240

Llega entre el 07 Jul y el 14 Jul a Santiago, Región Metropolitana. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Lung Cancer Screening (en Inglés)"

Lung cancer is the leading cause of cancer-related death among men and women in the U.S. and worldwide. For many decades, lung cancer was the sole cancer among the deadly four without an evidence-based screening method for decreasing mortality. This changed in November 2011, when findings from the National Lung Cancer Screening Trial showed low-dose lung CT screening was more efficacious in reducing deaths in high-risk individuals than conventional radiography. As such, an ever-increasing number of health organizations now recommend this screening protocol.Lung Cancer Screening by Mark Parker and esteemed VCU Health colleagues, fulfills the dire need for a comprehensive guide explaining the crucial aspects of lung cancer screenings. The first two chapters lay a foundation with discussion of lung cancer epidemiology and risk factors beyond cigarette smoking. Subsequent chapters cover the fundamentals, with clinical pearls on setting up a successful lung cancer screening program, patient eligibility criteria, imaging variances of tumors in the lungs, screening pros and cons, and interpreting/reporting screening results.The evolution and future of lung cancer screeningsDetection and management of unexpected incidental pulmonary and non-pulmonary findingsDiscussion of test cases utilizing the Lung-RADSTM risk-stratifying system for low-dose chest CT screeningsBenefits and potential harms associated with mass lung cancer screening programs including false positive, false negative, and over-diagnosis ratesThis state-of-the-art guide is essential reading for radiologists, oncologists, pulmonologists, and internists. It is a must-have bookshelf reference for hospital radiology and oncology departments, in particular for those setting up new lung cancer screening programs.